• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TCF3诱导DNMT1表达以调控胶质瘤中的Wnt信号通路。

TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.

作者信息

Zeng Wei, Jiang Haixiao, Wang Ying, Wang Cunzu, Yu Bo

机构信息

Medical College, Yangzhou University, Yangzhou, Jiangsu, 225000, People's Republic of China.

Department of Paediatrics, Lianyungang Third People's Hospital, Lianyungang, Jiangsu, 222000, People's Republic of China.

出版信息

Neurotox Res. 2022 Jun;40(3):721-732. doi: 10.1007/s12640-022-00510-w. Epub 2022 Apr 21.

DOI:10.1007/s12640-022-00510-w
PMID:35446002
Abstract

The epigenetic alteration is widely understood as the key to cancer initiation. Herein, we intended to clarify the role of transcription factor 3 (TCF3) in the development of glioma and the behind epigenetic mechanism. Through bioinformatics analysis, we identified a TCF3-DNA methyltransferase 1 (DNMT1)-secreted frizzled related protein 1 (SFRP1) axis which was differentially expressed and interacted in gliomas. More specifically, TCF3 activated DNMT1 transcription, and DNMT1 repressed SFRP1 expression. TCF3 and DNMT1 were overexpressed, while SFRP1 was downregulated in glioma. Functionally, TCF3 silencing inhibited cell proliferation and migration, and promoted apoptosis, which were reversed by DNMT1. SFRP1 inhibited the tumor supporting effects of DNMT1 on glioma cells. Moreover, TCF3 downregulation or SFRP1 overexpression inhibited tumorigenesis and enhanced apoptosis of glioma cells, while DNMT1 enhanced tumorigenesis and repressed apoptosis in tumor tissues in vivo. The Wnt pathway was a downstream effector of the TCF3-DNMT1-SFRP1 axis. Collectively, this study determined a novel therapeutic target TCF3 for glioma from the perspective of epigenetic alteration via regulation of SFRP1 expression in a DNMT1-dependent manner.

摘要

表观遗传改变被广泛认为是癌症发生的关键。在此,我们旨在阐明转录因子3(TCF3)在胶质瘤发展中的作用及其背后的表观遗传机制。通过生物信息学分析,我们鉴定出一条在胶质瘤中差异表达且相互作用的TCF3 - DNA甲基转移酶1(DNMT1)- 分泌型卷曲相关蛋白1(SFRP1)轴。更具体地说,TCF3激活DNMT1转录,而DNMT1抑制SFRP1表达。在胶质瘤中,TCF3和DNMT1过表达,而SFRP1下调。在功能上,TCF3沉默抑制细胞增殖和迁移,并促进凋亡,而DNMT1可逆转这些作用。SFRP1抑制DNMT1对胶质瘤细胞的肿瘤支持作用。此外,TCF3下调或SFRP1过表达抑制胶质瘤细胞的肿瘤发生并增强其凋亡,而DNMT1在体内肿瘤组织中增强肿瘤发生并抑制凋亡。Wnt通路是TCF3 - DNMT1 - SFRP1轴的下游效应器。总体而言,本研究从表观遗传改变的角度,通过以DNMT1依赖的方式调节SFRP1表达,确定了一种新的胶质瘤治疗靶点TCF3。

相似文献

1
TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.TCF3诱导DNMT1表达以调控胶质瘤中的Wnt信号通路。
Neurotox Res. 2022 Jun;40(3):721-732. doi: 10.1007/s12640-022-00510-w. Epub 2022 Apr 21.
2
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.乙型肝炎病毒 X 蛋白通过 Wnt 信号通路抑制 SFRP1 和 SFRP5 的表观遗传沉默增强肝癌细胞的致瘤性。
Int J Cancer. 2014 Aug 1;135(3):635-46. doi: 10.1002/ijc.28697. Epub 2014 Jan 13.
3
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.miR-328 通过 SFRP1 依赖性 Wnt 信号激活促进神经胶质瘤细胞侵袭。
Neuro Oncol. 2014 Jan;16(2):179-90. doi: 10.1093/neuonc/not164. Epub 2013 Dec 4.
4
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.丙型肝炎病毒核心蛋白通过诱导上皮-间充质转化,表观遗传沉默 SFRP1 并增强 HCC 的侵袭性。
Oncogene. 2014 May 29;33(22):2826-35. doi: 10.1038/onc.2013.225. Epub 2013 Jun 17.
5
Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.转录因子3控制多形性胶质母细胞瘤细胞系中的细胞增殖和迁移。
Biochem Cell Biol. 2016 Jun;94(3):247-55. doi: 10.1139/bcb-2015-0162. Epub 2016 Feb 22.
6
Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis .TCF3 在肾母细胞瘤中的表达及其对肾肿瘤细胞活力、迁移和凋亡的调控作用。
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12281. Epub 2021 Jul 19.
7
Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.DNMT1 介导的 Dok7 表达抑制促进神经胶质瘤细胞增殖。
Biomed Pharmacother. 2018 Oct;106:678-685. doi: 10.1016/j.biopha.2018.06.156. Epub 2018 Jul 11.
8
Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway.转录因子 3 的过表达通过激活 Wnt 信号通路促进细胞增殖从而驱动肝癌的发展。
Hepatobiliary Pancreat Dis Int. 2022 Aug;21(4):378-386. doi: 10.1016/j.hbpd.2022.01.003. Epub 2022 Jan 5.
9
Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.Wnt 信号通路上调 DNMT1 引发结肠癌中 NHERF1 启动子超甲基化。
Oncol Rep. 2018 Aug;40(2):1165-1173. doi: 10.3892/or.2018.6494. Epub 2018 Jun 14.
10
Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation.Wnt抑制在胶质瘤中失调,其重新建立可抑制增殖和肿瘤球形成。
Exp Cell Res. 2016 Jan 1;340(1):53-61. doi: 10.1016/j.yexcr.2015.12.010. Epub 2015 Dec 19.

引用本文的文献

1
Downregulation of ECRG4 by DNMT1 promotes EC growth via IRF3/IFN-γ/miR-29b/DNMT1/ECRG4 positive feedback loop.DNMT1对ECRG4的下调通过IRF3/IFN-γ/miR-29b/DNMT1/ECRG4正反馈环促进子宫内膜癌生长。
iScience. 2024 Dec 16;28(1):111614. doi: 10.1016/j.isci.2024.111614. eCollection 2025 Jan 17.
2
Human Milk Supports Robust Intestinal Organoid Growth, Differentiation, and Homeostatic Cytokine Production.人乳支持强大的肠道类器官生长、分化和稳态细胞因子产生。
Gastro Hep Adv. 2024 Jul 20;3(8):1030-1042. doi: 10.1016/j.gastha.2024.07.007. eCollection 2024.
3
Comprehensive analysis of mA/mC/mA-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in glioma.

本文引用的文献

1
Perioperative clinical trials for glioma: Raising the bar.脑胶质瘤围手术期临床试验:提高标准。
J Clin Neurosci. 2021 Jul;89:144-150. doi: 10.1016/j.jocn.2021.04.026. Epub 2021 May 11.
2
Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.脑胶质瘤复发和演变中的肿瘤内异质性、微环境和耐药机制。
Front Med. 2021 Aug;15(4):551-561. doi: 10.1007/s11684-020-0760-2. Epub 2021 Apr 24.
3
Differential Wnt-β- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications.
全面分析脑胶质瘤中 mA/mC/mA 相关基因表达、免疫浸润和抗肿瘤药物敏感性。
Front Immunol. 2022 Sep 20;13:955848. doi: 10.3389/fimmu.2022.955848. eCollection 2022.
HPV 阳性和阴性口腔上皮中差异 Wnt-β-连环蛋白通路的激活在头颈部肿瘤发生过程中传递:临床意义。
Med Microbiol Immunol. 2021 Feb;210(1):49-63. doi: 10.1007/s00430-020-00697-9. Epub 2020 Nov 23.
4
TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.TCF3 激活 FAM201A 通过 miR-186-5p/TNKS1BP1 轴增强三阴性乳腺癌中的细胞增殖和侵袭。
Bioorg Chem. 2020 Nov;104:104301. doi: 10.1016/j.bioorg.2020.104301. Epub 2020 Sep 22.
5
RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.RCC2 通过激活 DNMT1 的转录促进胶质母细胞瘤的增殖和放射抵抗。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):999-1006. doi: 10.1016/j.bbrc.2019.06.097. Epub 2019 Jul 2.
6
Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion.通过DNA甲基转移酶1介导的高甲基化下调KLF13可促进胶质瘤细胞的增殖和侵袭。
Onco Targets Ther. 2019 Feb 22;12:1509-1520. doi: 10.2147/OTT.S188270. eCollection 2019.
7
TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis.TCF3激活的LINC00152通过调控miR-1182/CDK14轴在骨肉瘤中发挥致癌作用。
Pathol Res Pract. 2019 Feb;215(2):373-380. doi: 10.1016/j.prp.2018.12.031. Epub 2018 Dec 26.
8
Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids.分泌卷曲相关蛋白 1(SFRP1)启动子甲基化下调瘢痕疙瘩中的 Wnt/β-连环蛋白活性。
J Mol Histol. 2018 Apr;49(2):185-193. doi: 10.1007/s10735-018-9758-3. Epub 2018 Feb 17.
9
Huai Qi Huang corrects the balance of Th1/Th2 and Treg/Th17 in an ovalbumin-induced asthma mouse model.槐杞黄纠正卵清蛋白诱导哮喘小鼠模型中 Th1/Th2 和 Treg/Th17 的失衡。
Biosci Rep. 2017 Dec 22;37(6). doi: 10.1042/BSR20171071.
10
Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.转录因子3的上调与宫颈癌的不良预后相关。
Int J Gynecol Cancer. 2017 Sep;27(7):1422-1430. doi: 10.1097/IGC.0000000000001032.